BFLY icon

Butterfly Network

1.66 USD
+0.09
5.73%
At close Updated Sep 15, 4:00 PM EDT
Pre-market
After hours
1.69
+0.03
1.81%
1 day
5.73%
5 days
6.41%
1 month
16.08%
3 months
-28.14%
6 months
-39.42%
Year to date
-58.19%
1 year
-9.29%
5 years
-83.1%
10 years
-83.23%
 

About: Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Employees: 190

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

90% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 39

25% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $986K

5.85% more ownership

Funds ownership: 47.18% [Q1] → 53.04% (+5.85%) [Q2]

0% more capital invested

Capital invested by funds: $233M [Q1] → $234M (+$1.08M) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

8% less funds holding

Funds holding: 204 [Q1] → 188 (-16) [Q2]

31% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 48

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$3
81% upside
Avg. target
$3
81% upside
High target
$3
81% upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Craig-Hallum
Chase Knickerbocker
$3
Buy
Initiated
1 Jul 2025

Financial journalist opinion

Based on 7 articles about BFLY published over the past 30 days

Positive
Zacks Investment Research
4 days ago
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management.
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
Neutral
Business Wire
6 days ago
Butterfly Network Appoints Victor Ku as Chief Technology Officer
BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap. “Victor's deep expertise.
Butterfly Network Appoints Victor Ku as Chief Technology Officer
Neutral
Business Wire
10 days ago
Rutgers Robert Wood Johnson Medical School Study Published in JAMA Confirms Butterfly-Enabled POCUS Program Heavily Focused on LUNG US with AI Assistance Reduces Stay and Cost
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced that the full results of the POCUS for Cardiopulmonary Assessment and Resource Evaluation (POCUS-CARE) trial have been published in The Journal of the American Medical Association (JAMA). The study, led by researchers at Rutgers Robert Wood Johnson Medical School (RWJMS).
Rutgers Robert Wood Johnson Medical School Study Published in JAMA Confirms Butterfly-Enabled POCUS Program Heavily Focused on LUNG US with AI Assistance Reduces Stay and Cost
Neutral
Business Wire
19 days ago
HeartFocus Launches First Clinical Product in the U.S. With Butterfly Network
BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch. HeartFocus will initially be available on Butterfly Network's handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions c.
HeartFocus Launches First Clinical Product in the U.S. With Butterfly Network
Positive
Zacks Investment Research
21 days ago
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
Neutral
Business Wire
21 days ago
Clipper Distributing and Butterfly Network Announce New Agreement
ST. JOSEPH, Mo.--(BUSINESS WIRE)--Clipper Distributing partners with Butterfly Network to increase access to high-quality, portable point-of-care diagnostic imaging for animals.
Clipper Distributing and Butterfly Network Announce New Agreement
Neutral
Business Wire
27 days ago
Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced settings. For patients in regions such as Sub-Saharan Africa (SSA) with no access to ultrasound in primary.
Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa
Positive
Zacks Investment Research
1 month ago
What Makes Butterfly Network (BFLY) a New Buy Stock
Butterfly Network (BFLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Butterfly Network (BFLY) a New Buy Stock
Neutral
The Motley Fool
1 month ago
Butterfly Q2 Margin Climbs to 63%
Butterfly Q2 Margin Climbs to 63%
Butterfly Q2 Margin Climbs to 63%
Neutral
Business Wire
1 month ago
Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its role in new research demonstrating the potential for machine learning (ML) models to support early detection of aortic stenosis (AS) using handheld ultrasound devices. The study, conducted by Tufts Medical Center and published in European Heart Journal – Imaging Methods and Practice, demon.
Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools
Charts implemented using Lightweight Charts™